These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 459514)

  • 21. Benign and malignant mesothelial proliferations.
    Koss LG
    Am J Surg Pathol; 2001 Apr; 25(4):548-9. PubMed ID: 11257637
    [No Abstract]   [Full Text] [Related]  

  • 22. Peculiar features of mesothelioma occurrence as related to exposure patterns and circumstances in the Lombard Region, Italy.
    Pesatori AC; Mensi C
    Med Lav; 2005; 96(4):354-9. PubMed ID: 16457432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of pirarubicin (4'-0-tetrahydropyranyladriamycin) in malignant mesothelioma.
    Sridhar KS; Hussein AM; Feun LG; Zubrod CG
    Cancer; 1989 Mar; 63(6):1084-91. PubMed ID: 2917312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritoneal mesothelioma after environmental asbestos exposure.
    Rosenthal R; Langer I; Dalquen P; Marti WR; Oertli D
    Swiss Surg; 2003; 9(6):311-4. PubMed ID: 14725101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A diffuse, pleural, malignant mesothelioma kept in long remission by chemotherapy combining pirarubicin and cisplatin].
    Niki Y; Soga T; Nishimura A; Kato M; Hamada M; Kanamaru M
    Gan No Rinsho; 1990 Nov; 36(14):2463-7. PubMed ID: 2250368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computed tomography findings in 66 patients with malignant pleural mesothelioma due to environmental exposure to asbestos.
    Okten F; Köksal D; Onal M; Ozcan A; Simşek C; Ertürk H
    Clin Imaging; 2006; 30(3):177-80. PubMed ID: 16632152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study.
    Roe OD; Creaney J; Lundgren S; Larsson E; Sandeck H; Boffetta P; Nilsen TI; Robinson B; Kjaerheim K
    Lung Cancer; 2008 Aug; 61(2):235-43. PubMed ID: 18281122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Malignant peritoneal mesothelioma].
    Beznea A; Truş CT; Chicoş SC; Chebac GR; Ceauşu M
    Chirurgia (Bucur); 2009; 104(2):227-30. PubMed ID: 19499669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Malignant peritoneal mesothelioma: its relation to asbestos].
    Pentimone F; Moruzzo D; Siuti E; del Corso L
    Minerva Med; 1995 Oct; 86(10):439-43. PubMed ID: 8622811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study.
    Samson MK; Wasser LP; Borden EC; Wanebo HJ; Creech RH; Phillips M; Baker LH
    J Clin Oncol; 1987 Jan; 5(1):86-91. PubMed ID: 3543239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Malignant peritoneal mesothelioma tumours. Evolution, treatment, prognosis].
    Scripcariu V; Dajbog E; Radu I; Ferariu D; Pricop A; Grigoraş M; Dragomir C
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):673-7. PubMed ID: 18293699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exfoliative cytology of diffuse mesothelioma.
    Roberts GH; Campbell GM
    J Clin Pathol; 1972 Jul; 25(7):577-82. PubMed ID: 5070255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and treatment of mesothelioma of the pleura].
    Abisatov KhA; Shaĭkhiev USh
    Ter Arkh; 1971 Mar; 43(3):103-6. PubMed ID: 5561185
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging.
    Steinert HC; Santos Dellea MM; Burger C; Stahel R
    Lung Cancer; 2005 Jul; 49 Suppl 1():S33-5. PubMed ID: 15950798
    [No Abstract]   [Full Text] [Related]  

  • 35. [Malignant peritoneal mesothelioma].
    Wambach G; Weller P; Pietsch M; Kaufmann W
    Dtsch Med Wochenschr; 1986 Mar; 111(13):517-8. PubMed ID: 3956396
    [No Abstract]   [Full Text] [Related]  

  • 36. [Imaging of peritoneal mesotheliomas].
    Lewin M; Arrivé L; Wendum D; Monnier-Cholley L; Bouttier E; Tubiana JM
    J Radiol; 1996 Sep; 77(9):649-56. PubMed ID: 8944121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant pleural mesothelioma presenting as achalasia.
    Seki H; Matsumoto K; Ohmura K; Fukushi Y; Fujita T; Kiriyama H; Takada H; Kamii K; Terada H; Mori Y
    Intern Med; 1994 Oct; 33(10):624-7. PubMed ID: 7827380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph node metastasis as the initial manifestation of malignant mesothelioma. Report of six cases.
    Sussman J; Rosai J
    Am J Surg Pathol; 1990 Sep; 14(9):819-28. PubMed ID: 2389813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant pleural mesothelioma in pregnancy.
    Ramsey PS; Danilenko-Dixon DR; Ramin KD; Ogburn PL
    J Matern Fetal Med; 2000; 9(6):373-5. PubMed ID: 11243299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent hydropneumothorax as a presenting feature of malignant mesothelioma.
    Guha K; Jones D; Hull JH; Ho TB
    Eur J Intern Med; 2008 Jan; 19(1):63-4. PubMed ID: 18206605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.